EDITOR—The interesting drug point by Farley-Hills et al, on fatal liver failure associated with pioglitazone, is missing data.1 I hope that it will remind doctors to monitor liver function and not cause a scare similar to that which …
No takes yet. Share an insight, caveat, or question.
Peshraw Amin (2004) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: